Transgenomic Inc Stock Nasdaq
Equities
US89365K3059
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
May. 14 | Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
Financials (USD)
Sales 2022 | 9.41M | Sales 2023 | 15.2M | Capitalization | 9.23M |
---|---|---|---|---|---|
Net income 2022 | -12M | Net income 2023 | -5M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M | Net cash position 2023 | 386K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.88% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 40 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 81 | 19-12-02 |
1st Jan change | Capi. | |
---|---|---|
-56.07% | 2.17B | |
+19.09% | 1.88B | |
-12.63% | 1.45B | |
+29.99% | 1.32B | |
+8.32% | 853M | |
-30.60% | 799M | |
-36.50% | 726M | |
+29.48% | 622M | |
-29.02% | 594M |